#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>Effective February 19, 2013
*ExistRefRange>
#ExistRefRangeTable> | Therapeutic Range
| Not well established
| | Toxic Level
| Greater than 25.0 µg/mL
|
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>A proposed therapeutic range is 1.0-3.5 µg/mL for a 2 g/day dose. A 3 g/day dose may have plasma concentrations up to 5.0 µg/mL. Trough concentrations between 2.0 and 4.0 µg/mL have been suggested to maximize efficacy and minimize adverse effects. Adverse effects of toxicity include abdominal pain, peripheral edema, cardiac abnormalities, hypertension and electrolyte disturbances.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
80299
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Cellcept™ (Mycophenolic Acid)
, CellCept™ MPA (Mycophenolic Acid)
, Mofetil Ester (Mycophenolic Acid), Mycophenolate (Mycophenolic Acid), Mycophenolate Mofetil (Mycophenolic Acid), Myfortic™ (Mycophenolic Acid)
, Prodrug (Mycophenolic Acid) |
*ExistCrossReferences>